From the sample to the sequence, and from one result to lasting knowledge
Hereditary cancer genetic testing is a chain of careful steps: a sample is collected, DNA is extracted and read, variants are interpreted against the medical literature, and — when many results are gathered over time in a registry — patterns emerge that no single test could reveal. This hub explains that machinery as science and process, not as a product to buy.
Genetic Testing & Patient Registries
A result is only as reliable as the sample it came from
Every genetic result begins with a physical sample, and the quality of that sample sets the ceiling on what the laboratory can determine. A saliva tube contaminated with food, a buccal swab that collected too few cells, or a blood specimen degraded in transit can all reduce the amount of intact DNA available for sequencing — sometimes enough to force a re-collection.
This is why the unglamorous early steps deserve attention. Correct collection technique, stabilizing preservatives, and controlled shipping conditions are not formalities; they are what allow a downstream sequencer to read your genome accurately. Understanding the journey from collection to result helps patients and clinicians know what a test can — and cannot — confidently tell them.
From sample to sequence to shared knowledge
The path a hereditary-cancer test travels is consistent across methods. Each stage has a purpose, and each can affect how confidently a result can be interpreted.
1. Collection
Cells are gathered from saliva, a cheek swab, or a blood draw. Stabilizing buffers preserve DNA so the specimen survives handling and shipping intact.
2. Extraction
In the laboratory, DNA is separated from the rest of the sample and assessed for quantity and quality before any sequencing begins.
3. Sequencing
A multi-gene panel reads the targeted hereditary-cancer genes, generating the raw genetic data that will be analyzed for clinically meaningful variants.
4. Interpretation
Detected variants are compared against medical and population databases and classified — from benign to pathogenic — by laboratory scientists and the evidence available.
5. Reporting & registry
A result is returned to the ordering clinician. Aggregated across many consenting patients in a registry, those results become longitudinal data that sharpens future interpretation.
Explore the five areas of this hub
Each guide goes deeper into one part of the testing and registry pipeline — written for patients, genetic counselors, and curious readers alike.
How Multi-Gene Panel Testing Works
What a hereditary-cancer panel actually reads, how variants are classified, and how to interpret positive, negative, and uncertain results.
Read the guideCollecting a Genetic Sample
Saliva tubes, buccal swabs, and blood draws compared — the technique behind each and why collection quality shapes reliability.
Read the guideFrom Sample to Sequence
Follow a specimen through extraction, library preparation, and sequencing to see how physical DNA becomes a readable result.
Read the guidePatient Registries Explained
What a registry like PROMPT does, why longitudinal follow-up matters, and how many individual results become durable scientific knowledge.
Read the guideUnderstanding Your Results
Pathogenic, benign, and variants of uncertain significance — what each classification means and how interpretations can change over time.
Read the guideHow registries turn many results into durable knowledge
An individual genetic result answers a personal question. A registry answers a scientific one. By following thousands of consenting patients who underwent multi-gene panel testing — the approach behind the PROMPT Study (Prospective Registry Of MultiPlex Testing) — researchers can observe how specific variants behave across diverse populations and over years of follow-up.
This longitudinal view is what allows a variant once labeled 'uncertain' to be reclassified as benign or pathogenic as evidence accumulates. Registries do not sell anything; they build the shared reference against which every future result is read more accurately. The quality of each contributing sample, once again, feeds the reliability of the whole.
Frequently asked questions
Does the type of sample change the result?
The underlying genome is identical whether it comes from saliva, a cheek swab, or blood, so a well-collected sample of any type can yield the same hereditary-cancer information. What differs is yield and stability: blood typically provides abundant, high-quality DNA, while saliva and swabs depend more heavily on correct collection technique to capture enough intact cells.
What is a multi-gene panel, and how is it different from single-gene testing?
A panel reads many hereditary-cancer-associated genes in one analysis rather than testing a single gene like BRCA1 in isolation. This can identify risk that a narrower test would miss, but it also raises the chance of finding a variant of uncertain significance — which is one reason interpretation and registry follow-up are so important.
What does it mean if my result is a 'variant of uncertain significance'?
It means a genetic change was detected, but the current evidence is not sufficient to confidently call it harmful or harmless. These classifications are not permanent — as registries gather more data on how the same variant behaves across many people, laboratories may reclassify it. Management decisions are generally not based on uncertain variants alone.
What happens to my sample and data after testing?
Handling depends on the laboratory and any registry you consent to join. In a research registry, de-identified results may be retained and followed over time to improve scientific understanding. This page is educational; specific retention, consent, and privacy terms come from the laboratory and registry involved in your care.
Have a question about hereditary cancer genetics?
We publish independent, evidence-minded explainers on genetic testing and patient registries. If something here raised a question you'd like clarified, reach out — we're glad to point you to the right reference material.